Clinical Trial Update: YUKON Choice Versus TAXUS Liberté in Diabetes Mellitus [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing the YUKON Choice drug-eluting stent with TAXUS Liberté in patients with coronary arteriosclerosis in the context of diabetes mellitus …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Arteriosclerosis
• Diabetes Mellitus

Drugs mentioned

• TAXUS Liberté (paclitaxel-eluting stent)
• YUKON Choice

Snippet

Sponsor: University of Leipzig | Conditions: Coronary Arteriosclerosis | Phase 4 | Status: COMPLETED